Skip to content

Clinical trials

Phase 3 Epilepsy trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Israel Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20081
20102
20112
20122
20131
20142
20154
20181
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB BIOSCIENCES, Inc.4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Xenon Pharmaceuticals Inc.3
GlaxoSmithKline2
UCB Biopharma S.P.R.L.2
UCB Pharma2
Upsher-Smith Laboratories2
Eisai Inc.1
Jazz Pharmaceuticals1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy22
Seizures8
Epilepsies, Partial3
Epilepsies, Myoclonic1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.